Sec Form 4 Filing - Greenberg Robert J. @ SECOND SIGHT MEDICAL PRODUCTS INC - 2016-06-02

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Greenberg Robert J. 2. Issuer Name and Ticker or Trading Symbol SECOND SIGHT MEDICAL PRODUCTS INC [ EYES] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X __ Director _____ 10% Owner X __ Officer (give title below) _____ Other (specify below) Chairman of Board (Last) (First) (Middle) 12744 SAN FERNANDO ROAD, SUITE 400 3. Date of Earliest Transaction (MM/DD/YY) 06/02/2016 (Street) SYLMAR, CA91342 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 06/02/2016 06/02/2016 S 8,571 ( 1 ) D $ 4.1 172,911 D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Non-Qualified Stock Option (right to buy) $ 4.1 01/21/2017( 2 ) 01/21/2026 Common Stock 57,563 57,563 D Non-Qualified Stock Option (right to buy) $ 4.25 01/01/2014( 3 ) 01/01/2017 Common Stock 125,000 125,000 D Non-Qualified Stock Option (right to buy) $ 5 01/01/2008( 4 ) 01/01/2017 Common Stock 30,625 30,625 D Non-Qualified Stock Option (right to buy) $ 5 02/01/2009( 4 ) 02/01/2018 Common Stock 23,750 23,750 D Non-Qualified Stock Option (right to buy) $ 5 11/01/2009( 4 ) 11/01/2018 Common Stock 150,000 150,000 D Non-Qualified Stock Option (right to buy) $ 5 02/01/2010( 4 ) 02/01/2019 Common Stock 33,750 33,750 D Non-Qualified Stock Option (right to buy) $ 5 02/01/2011( 4 ) 02/01/2020 Common Stock 103,750 103,750 D Non-Qualified Stock Option (right to buy) $ 5 03/01/2012( 4 ) 03/01/2021 Common Stock 41,563 41,563 D Non-Qualified Stock Option (right to buy) $ 5 03/01/2013( 4 ) 03/01/2022 Common Stock 38,750 38,750 D Non-Qualified Stock Option (right to buy) $ 5 04/01/2015( 4 ) 04/01/2024 Common Stock 46,875 46,875 D Non-Qualified Stock Option (right to buy) $ 9 09/26/2015( 4 ) 09/26/2024 Common Stock 414,659 414,659 D Non-Qualified Stock Option (right to buy) $ 13.09 03/25/2016( 4 ) 03/25/2025 Common Stock 31,250 31,250 D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Greenberg Robert J. 12744 SAN FERNANDO ROAD SUITE 400 SYLMAR, CA91342 X Chairman of Board Signatures Robert J Greenberg 06/03/2016 Signature of Reporting Person Date

Explanation of Responses:

( 1 )8571 shares, acquired as part of scheduled ESPP purchases, were sold on 6/2/2016. ( 2 )Options vest over a four year term of which one-fourth vests on the Date Exercisable, with the remaining options vesting quarterly over three years thereafter. ( 3 )Options vested at date of grant ( 4 )Options vest in 4 yearly increments starting with the Date Exercisable

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.